Skip to content
OncoSantPau路 @OncoSantPau 路 X路路 17 hours agoScore70

palbociclib

Body

#ESMO26 #OncoSantpau 馃敐馃敐馃敐
@IRSantPau @HospitalSantPau
馃У鈴笍

39 views 路 1 like 路 1 repost 路 2 replies

Conference abstracts
LBA16matched by Rapid oral 1: Breast cancer, advanced stage

VIKTORIA-1: Updated results of a randomized, open-label, phase 3 study of gedatolisib (geda) + fulvestrant (fulv) 卤 palbociclib (palbo) vs standard of care in patients (pts) with HR+/HER2- advanced breast cancer (ABC) (Study 2)

https://esmocongress.esmo.org
Replies in this thread
  1. OncoSantPau@OncoSantPau

    @margamajem @andres_bj87 La Dra.Andr茅s i la Dra.Arqueros presenten un estudi de biomarcadors farmacogen猫tics del tractament amb palbociclib per c脿ncer de mama.

  2. OncoSantPau@OncoSantPau

    El Dr.Mart铆nez i l鈥檈quip de tumors tor脿cics-melanoma presenten els resultats d鈥檜n estudi multic猫ntric de tractament anti-PD-1 adjuvant en melanoma.

Source: OncoSantPau 路 x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org